Intelligent Bio Solutions (INBS) Long-Term Investments (2020)
Intelligent Bio Solutions' quarterly Long-Term Investments came in at $135692.0 in Q2 2020.
Intelligent Bio Solutions has reported Long-Term Investments for 1 years, with the latest figure at $135692.0 in Q2 2020.
- For the quarter ending Q2 2020, Long-Term Investments changed N/A year-over-year to $135692.0; the trailing twelve-month figure through Jun 2020 stood at $135692.0 (changed N/A YoY), and the FY2020 full-year result was $135692.0, changed N/A from the prior year.
- Long-Term Investments for Q2 2020 stood at $135692.0.
- The five-year high for Long-Term Investments was $135692.0 in Q2 2020, with the low at $135692.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 135,692.00 |